应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LONA LeonaBio Inc
已收盘 11-18 16:00:00 EST
2.65
-0.11
-3.99%
盘后
2.55
-0.10
-3.77%
19:56 EST
最高
3.05
最低
2.51
成交量
4.45万
今开
2.77
昨收
2.76
日振幅
19.62%
总市值
3,465万
流通市值
1,883万
总股本
1,308万
成交额
12.14万
换手率
0.63%
流通股本
710.40万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
LeonaBio完成拉索昔芬联合阿贝西利III期ELAIN-3试验第500例受试者入组——SEC文件披露
美股速递 · 08-27
LeonaBio完成拉索昔芬联合阿贝西利III期ELAIN-3试验第500例受试者入组——SEC文件披露
加载更多
公司概况
公司名称:
LeonaBio Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
LeonaBio, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology,Inc.,并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司,致力于开发小型药物分子来恢复神经元健康并阻止神经变性。其主要药物候选者lasofoxifene和ATH-1105是新型小分子疗法,旨在针对当前治疗选择有限或无效的破坏性疾病。LeonaBio 坚持追求科学卓越和以患者为中心的创新,致力于为最需要帮助的人开发具有实际意义的新疗法。
发行价格:
--
{"stockData":{"symbol":"LONA","market":"US","secType":"STK","nameCN":"LeonaBio Inc","latestPrice":2.65,"timestamp":1795035600000,"preClose":2.76,"halted":0,"volume":44498,"hourTrading":{"tag":"盘后","latestPrice":2.55,"preClose":2.65,"latestTime":"19:56 EST","volume":173,"amount":442.25,"timestamp":1795049793222,"change":-0.1,"changeRate":-0.037736,"amplitude":0.037736},"delay":0,"changeRate":-0.03985507246376807,"floatShares":7104000,"shares":13076348,"eps":-10.876901,"marketStatus":"已收盘","change":-0.11,"latestTime":"11-18 16:00:00 EST","open":2.77,"high":3.0516,"low":2.51,"amount":121434.0897428,"amplitude":0.196232,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-10.876901,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1795078800000},"marketStatusCode":5,"adr":0,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":2.76,"postHourTrading":{"tag":"盘后","latestPrice":2.55,"preClose":2.65,"latestTime":"19:56 EST","volume":173,"amount":442.25,"timestamp":1795049793222,"change":-0.1,"changeRate":-0.037736,"amplitude":0.037736},"volumeRatio":1.375909},"requestUrl":"/m/hq/s/LONA","defaultTab":"news","newsList":[{"id":"1103736186","title":"LeonaBio完成拉索昔芬联合阿贝西利III期ELAIN-3试验第500例受试者入组——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103736186","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103736186?lang=zh_cn&edition=full","pubTime":"2026-08-27 04:40","pubTimestamp":1787776809,"startTime":"0","endTime":"0","summary":"LeonaBio宣布,其拉索昔芬联合阿贝西利方案的III期ELAIN-3临床试验已成功完成第500例受试者入组。这一里程碑式的进展已在最新提交给美国证券交易委员会(SEC)的文件中正式披露。\n值得关注的是,ELAIN-3试验旨在评估拉索昔芬与CDK4/6抑制剂阿贝西利联用的疗效与安全性。此次入组人数的突破,标志着该研究项目在推进过程中迈出了坚实的一步。通过SEC文件的公开信息,市场得以一窥这一关键节点的最新动态。\n业内观察人士认为,随着受试者招募工作的持续推进,该试验的数据积累正逐步走向成熟,未来有望为相关治疗领域提供更具说服力的循证依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LONA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leonabio.com","stockEarnings":[{"period":"1week","weight":-0.3134},{"period":"1month","weight":-0.4692},{"period":"3month","weight":-0.6475},{"period":"6month","weight":-0.7259},{"period":"1year","weight":-0.4},{"period":"ytd","weight":-0.6354}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0404},{"period":"3month","weight":-0.0476},{"period":"6month","weight":-0.0138},{"period":"1year","weight":0.1003},{"period":"ytd","weight":0.0741}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LeonaBio, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology,Inc.,并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司,致力于开发小型药物分子来恢复神经元健康并阻止神经变性。其主要药物候选者lasofoxifene和ATH-1105是新型小分子疗法,旨在针对当前治疗选择有限或无效的破坏性疾病。LeonaBio 坚持追求科学卓越和以患者为中心的创新,致力于为最需要帮助的人开发具有实际意义的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.081093},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02158},{"month":3,"riseRate":0.333333,"avgChangeRate":0.058482},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.076601},{"month":5,"riseRate":0.666667,"avgChangeRate":0.062747},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.190735},{"month":7,"riseRate":0.5,"avgChangeRate":0.049928},{"month":8,"riseRate":0.5,"avgChangeRate":-0.008327},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.278212},{"month":10,"riseRate":0.571429,"avgChangeRate":0.086531},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058411},{"month":12,"riseRate":0.666667,"avgChangeRate":0.280766}],"exchange":"NASDAQ","name":"LeonaBio Inc","nameEN":"LeonaBio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LeonaBio Inc(LONA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LeonaBio Inc(LONA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LeonaBio Inc,LONA,LeonaBio Inc股票,LeonaBio Inc股票老虎,LeonaBio Inc股票老虎国际,LeonaBio Inc行情,LeonaBio Inc股票行情,LeonaBio Inc股价,LeonaBio Inc股市,LeonaBio Inc股票价格,LeonaBio Inc股票交易,LeonaBio Inc股票购买,LeonaBio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LeonaBio Inc(LONA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LeonaBio Inc(LONA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}